Autolus Therapeutics (AUTL) Capital Expenditures (QoQ) (2019 - 2025)
Autolus Therapeutics (AUTL) Capital Expenditures (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -120.08% |
| Sep 30, 2025 | -39.43% |
| Jun 30, 2025 | -11.72% |
| Mar 31, 2025 | -25.82% |
| Dec 31, 2024 | 15.88% |
| Sep 30, 2024 | 1,070.82% |
| Jun 30, 2024 | 47.57% |
| Mar 31, 2024 | -62.42% |
| Dec 31, 2023 | -1.40% |
| Sep 30, 2023 | -65.32% |
| Jun 30, 2023 | 16.98% |
| Mar 31, 2023 | 483.25% |
| Dec 31, 2022 | -88.04% |
| Sep 30, 2022 | 27.73% |
| Jun 30, 2022 | 437.48% |
| Mar 31, 2022 | -51.36% |
| Dec 31, 2021 | -58.95% |
| Sep 30, 2021 | 155.53% |
| Jun 30, 2021 | -20.47% |
| Mar 31, 2021 | -65.28% |